1. Home
  2. PHAR vs HLIT Comparison

PHAR vs HLIT Comparison

Compare PHAR & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.39

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$10.43

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
HLIT
Founded
1988
1988
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PHAR
HLIT
Price
$16.39
$10.43
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$30.00
$13.13
AVG Volume (30 Days)
21.0K
1.1M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
0.43
Revenue
$362,274,000.00
$635,710,000.00
Revenue This Year
$24.80
N/A
Revenue Next Year
$6.84
$21.80
P/E Ratio
$3,084.39
$24.18
Revenue Growth
26.78
1.93
52 Week Low
$7.50
$7.80
52 Week High
$18.12
$13.75

Technical Indicators

Market Signals
Indicator
PHAR
HLIT
Relative Strength Index (RSI) 49.79 58.97
Support Level $15.76 $10.28
Resistance Level $18.12 $10.75
Average True Range (ATR) 0.83 0.31
MACD -0.12 0.12
Stochastic Oscillator 28.81 74.83

Price Performance

Historical Comparison
PHAR
HLIT

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: